These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28398414)

  • 61. Are Systemic Corticosteroids Causing Psoriasis Flare-Ups? Questionnaire for Danish Dermatologists, Gastroenterologists and Rheumatologists.
    Schwarz CW; Loft N; Andersen V; Juul L; Zachariae C; Skov L
    Dermatology; 2021; 237(4):588-594. PubMed ID: 33049749
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Access to injectable biologic medications by medicare beneficiaries: geographic distribution of US dermatologist prescribers.
    Feng H; Cohen JM; Neimann AL
    J Dermatolog Treat; 2019 May; 30(3):237-239. PubMed ID: 30078341
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development and testing of a web module to IMPROVE generic prescribing of oral contraceptives among primary care physicians.
    Lenti G; Norenberg A; Farnan JM; Weissman A; Cook M; Shah N; Moriates C; Wallingford S; Lynch S; Stebbins M; Millard S; Samarth A; Zhang JX; Thaver A; Meltzer DO; Oguntimein M; Frost M; Arora VM
    J Clin Pharm Ther; 2019 Aug; 44(4):579-587. PubMed ID: 31152684
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Discordance of pediatric morphea treatment by pediatric dermatologists.
    Tollefson MM; Chiu YE; Brandling-Bennett HA; Pope E
    Pediatr Dermatol; 2018 Jan; 35(1):47-54. PubMed ID: 29165838
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
    Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Survey Study of Human Papillomavirus Vaccination Practices by Dermatologists.
    Cartron AM; Raiciulescu S; Trinidad JC
    J Drugs Dermatol; 2020 Apr; 19(4):431-432. PubMed ID: 32401459
    [No Abstract]   [Full Text] [Related]  

  • 67. Melanoma Reporting Practices of United States Dermatologists.
    Svoboda RM; Glazer AM; Farberg AS; Cowdrey MCE; Rigel DS
    Dermatol Surg; 2018 Nov; 44(11):1391-1395. PubMed ID: 29847335
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chronic Spontaneous Urticaria (CSU): Canadian Dermatologists' Perspective.
    Cheung LY; Lynde CW
    J Cutan Med Surg; 2016 Jul; 20(4):308-12. PubMed ID: 26834118
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].
    Botzenhardt S; Toni I; Rascher W; Neubert A
    Klin Padiatr; 2013 Sep; 225(5):268-76. PubMed ID: 23979828
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Women's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice.
    Smith LF; Whitfield MJ
    Br J Gen Pract; 1995 Aug; 45(397):409-14. PubMed ID: 7576845
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Keratoacanthoma management: results of a survey of U.K. dermatologists and surgeons.
    Watchorn RE; Thomas S; Miller C; Carr RA; Koch D; Thomas P; Taibjee SM
    Br J Dermatol; 2018 Jan; 178(1):e49-e50. PubMed ID: 28758190
    [No Abstract]   [Full Text] [Related]  

  • 72. The diminishing presence of dermatologists in the care of hospitalized patients receiving Medicare benefits.
    Kakpovbia E; Kim RH; Cohen DE; Ogbechie-Godec OA
    J Am Acad Dermatol; 2020 Aug; 83(2):640-643. PubMed ID: 31682860
    [No Abstract]   [Full Text] [Related]  

  • 73. Combined oral contraceptives for the treatment of acne: a practical guide.
    Arrington EA; Patel NS; Gerancher K; Feldman SR
    Cutis; 2012 Aug; 90(2):83-90. PubMed ID: 22988652
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Isotretinoin prescribing and monitoring practices among Australian dermatologists measured against current guidelines, and identification of practice uncertainties.
    Manuelpillai N; Veysey E
    Clin Exp Dermatol; 2022 Apr; 47(4):770-773. PubMed ID: 34856005
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Attitudes of female patients regarding oral contraceptives for treatment of acne.
    Tan JK; Vasey K; Fung KY
    J Cutan Med Surg; 2001; 5(6):471-4. PubMed ID: 11907854
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
    Dickerson V
    J Reprod Med; 2002 Nov; 47(11 Suppl):985-93. PubMed ID: 12497673
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drospirenone/ethinyl estradiol.
    Rapkin AJ; Sorger SN; Winer SA
    Drugs Today (Barc); 2008 Feb; 44(2):133-45. PubMed ID: 18389090
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Advances in the treatment of acne.
    Kimball AB
    J Reprod Med; 2008 Sep; 53(9 Suppl):742-52. PubMed ID: 18980046
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Compounded preparations in dermatology - analysis of prescribing habits in everyday clinical practice in Germany.
    Salzmann S; Salzmann M; Staubach P
    J Dtsch Dermatol Ges; 2020 Apr; 18(4):334-340. PubMed ID: 32247288
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment.
    Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
    J Drugs Dermatol; 2009 Sep; 8(9):837-44. PubMed ID: 19746676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.